Magnus Corfitzen

CEO at Ascelia Pharma

Magnus Corfitzen (born 1975) has extensive experience in investing, building, and growing Life Science companies in various roles including operational activities or investment responsibilities for public and private biotech and medtech companies. Magnus Corfitzen also has board experience from a number of Life Science companies. Magnus Corfitzen has previously been Investment Director at Sunstone Capital A/S and Investment Director at Vækstfonden (the Danish Growth Fund). Prior to entering the healthcare venture capital field, he was a Portfolio Manager at Danske Capital with responsibility for investments into listed biotech and medtech companies and he started his career at McKinsey & Company.

Links

Previous companies

Sunstone Life Science Ventures logo

Timeline

  • A

    CEO

    January, 2014 - present